These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 1331389

  • 21. Hereditary vitamin D-resistant rickets: a report of four cases with two novel variants in the VDR gene and successful use of intermittent intravenous calcium via a peripheral route.
    Abalı S, Tamura M, Turan S, Atay Z, Isguven P, Güran T, Haliloglu B, Baş S, Isojima T, Kitanaka S, Bereket A.
    J Pediatr Endocrinol Metab; 2020 Apr 28; 33(4):557-562. PubMed ID: 32049653
    [Abstract] [Full Text] [Related]

  • 22. Rickets and alopecia with resistance to 1,25-dihydroxyvitamin D: two different clinical courses with two different cellular defects.
    Balsan S, Garabedian M, Liberman UA, Eil C, Bourdeau A, Guillozo H, Grimberg R, Le Deunff MJ, Lieberherr M, Guimbaud P, Broyer M, Marx SJ.
    J Clin Endocrinol Metab; 1983 Oct 28; 57(4):803-11. PubMed ID: 6309886
    [Abstract] [Full Text] [Related]

  • 23. Acute effects of calcitriol and phosphate salts on mineral metabolism in children with hypophosphatemic rickets.
    Bettinelli A, Bianchi ML, Mazzucchi E, Gandolini G, Appiani AC.
    J Pediatr; 1991 Mar 28; 118(3):372-6. PubMed ID: 1847972
    [Abstract] [Full Text] [Related]

  • 24. Different mechanisms of intestinal calcium absorption at different life stages: therapeutic implications and long-term responses to treatment in patients with hereditary vitamin D-resistant rickets.
    Chaturvedi D, Garabedian M, Carel JC, Léger J.
    Horm Res Paediatr; 2012 Mar 28; 78(5-6):326-31. PubMed ID: 22965178
    [Abstract] [Full Text] [Related]

  • 25. Hereditary resistance to 1,25-dihydroxyvitamin D: clinical and radiological improvement during high-dose oral calcium therapy.
    Sakati N, Woodhouse NJ, Niles N, Harfi H, de Grange DA, Marx S.
    Horm Res; 1986 Mar 28; 24(4):280-7. PubMed ID: 3023230
    [Abstract] [Full Text] [Related]

  • 26. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V, Torregrosa V.
    Nefrologia; 2008 Mar 28; 28 Suppl 3():67-78. PubMed ID: 19018742
    [Abstract] [Full Text] [Related]

  • 27. Calcitriol-resistant rickets with alopecia.
    Hochberg Z, Gilhar A, Haim S, Friedman-Birnbaum R, Levy J, Benderly A.
    Arch Dermatol; 1985 May 28; 121(5):646-7. PubMed ID: 2986561
    [Abstract] [Full Text] [Related]

  • 28. X-linked hypophosphatemic rickets: a study (with literature review) of linear growth response to calcitriol and phosphate therapy.
    Petersen DJ, Boniface AM, Schranck FW, Rupich RC, Whyte MP.
    J Bone Miner Res; 1992 Jun 28; 7(6):583-97. PubMed ID: 1414477
    [Abstract] [Full Text] [Related]

  • 29. Effects of therapy in X-linked hypophosphatemic rickets.
    Verge CF, Lam A, Simpson JM, Cowell CT, Howard NJ, Silink M.
    N Engl J Med; 1991 Dec 26; 325(26):1843-8. PubMed ID: 1660098
    [Abstract] [Full Text] [Related]

  • 30. 1,25-Dihydroxyvitamin D resistance, rickets, and alopecia.
    Hochberg Z, Benderli A, Levy J, Vardi P, Weisman Y, Chen T, Feldman D.
    Am J Med; 1984 Nov 26; 77(5):805-11. PubMed ID: 6548607
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The effect of recombinant human growth hormone in children with X-linked hypophosphatemia.
    Seikaly MG, Brown R, Baum M.
    Pediatrics; 1997 Nov 26; 100(5):879-84. PubMed ID: 9346990
    [Abstract] [Full Text] [Related]

  • 34. Oral calcium treatment in vitamin D-dependent rickets type II.
    Wong GW, Leung SS, Law WY, Cheung NK, Oppenheimer SJ.
    J Paediatr Child Health; 1994 Oct 26; 30(5):444-6. PubMed ID: 7833085
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Early treatment of familial hypophosphataemic rickets.
    Roza M, Miguel MA, Galbe M, Mejido L, Mencia C.
    Arch Dis Child; 1983 Dec 26; 58(12):1020-2. PubMed ID: 6689262
    [Abstract] [Full Text] [Related]

  • 38. Vitamin D-resistant rickets associated with epidermal nevus syndrome: demonstration of a phosphaturic substance in the dermal lesions.
    Aschinberg LC, Solomon LM, Zeis PM, Justice P, Rosenthal IM.
    J Pediatr; 1977 Jul 26; 91(1):56-60. PubMed ID: 195029
    [Abstract] [Full Text] [Related]

  • 39. A trial of growth hormone therapy in well-controlled hypophosphataemic rickets.
    Cameron FJ, Sochett EB, Daneman A, Kooh SW.
    Clin Endocrinol (Oxf); 1999 May 26; 50(5):577-82. PubMed ID: 10468922
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.